RCEL
Avita Medical Ltd
13.30$
+4.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.0% | -21.8% | +36.8% | +28.6% | -5.8% | +0.6% | -0.5% | -7.4% | +3.2% | +9.3% | +12.7% | – | |
| – | -15.0% | -15.8% | +39.5% | +51.1% | -28.5% | +24.3% | +22.4% | -8.1% | +3.7% | +6.6% | +11.7% | – | |
| – | +7.5% | -22.6% | +36.4% | +25.0% | -1.4% | -2.8% | -4.7% | -7.2% | +3.1% | +9.9% | +13.0% | – | |
| – | +54.0% | -23.2% | -5.9% | +11.1% | -10.6% | +29.6% | -18.6% | -26.8% | +51.8% | -1.1% | -9.8% | – | |
| – | +26.6% | +15.7% | -16.1% | +27.5% | -25.7% | -10.3% | +4.3% | +8.4% | -1.9% | -14.5% | -1.5% | – | |
| – | +18.4% | +8.6% | +7.1% | +5.1% | -13.5% | +5.5% | -5.1% | -11.8% | +7.3% | -0.8% | +0.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11,120.0% | +20.9% | -0.7% | +0.9% | -4.5% | -5.0% | +1.5% | +1.3% | -1.4% | +13.9% | +2.7% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +9.1% | +150.0% | +10.0% | -184.8% | – | -57.9% | -50.0% | +275.0% | -213.3% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.